Table of Contents
Postoperative nausea and vomiting (PONV) is a common complication after surgery, affecting patient comfort and recovery. Effective management of PONV involves the use of antiemetic medications. This review explores the various classes of antiemetics used in clinical practice, their mechanisms, efficacy, and safety profiles.
Understanding Postoperative Nausea and Vomiting (PONV)
PONV occurs in approximately 20-30% of surgical patients, with higher rates in certain populations such as women, non-smokers, and those undergoing specific procedures like laparoscopic or ENT surgeries. It can lead to dehydration, electrolyte imbalance, increased hospital stay, and patient dissatisfaction.
Classes of Antiemetics Used in PONV
- Serotonin (5-HT3) receptor antagonists
- Neurokinin-1 (NK1) receptor antagonists
- Antihistamines
- Anticholinergics
- Dopamine receptor antagonists
- Glucocorticoids
Serotonin (5-HT3) Receptor Antagonists
This class includes drugs such as ondansetron, granisetron, and palonosetron. They block serotonin receptors in the chemoreceptor trigger zone and gastrointestinal tract, effectively reducing nausea and vomiting. They are considered first-line agents due to their efficacy and safety profile.
Neurokinin-1 (NK1) Receptor Antagonists
Agents like aprepitant and fosaprepitant target NK1 receptors in the central nervous system. They are particularly useful for preventing delayed PONV and are often combined with 5-HT3 antagonists for enhanced effect.
Antihistamines
Hydroxyzine, promethazine, and diphenhydramine are common antihistamines used for PONV. They have sedative properties but are associated with anticholinergic side effects such as dry mouth and drowsiness.
Anticholinergics
Scopolamine, administered via transdermal patches, is effective in PONV prevention. It acts by blocking muscarinic receptors in the vestibular system, making it especially useful in motion sickness-related nausea.
Dopamine Receptor Antagonists
Metoclopramide and droperidol are examples. They work by antagonizing dopamine receptors in the chemoreceptor trigger zone. However, their use is limited by potential side effects such as extrapyramidal symptoms and QT prolongation.
Glucocorticoids
Dexamethasone is commonly used as an adjunct in PONV prophylaxis. Its anti-inflammatory properties help reduce nausea, and it has a favorable safety profile when used in recommended doses.
Comparative Efficacy and Safety
Multiple studies have demonstrated that combination therapy, such as a 5-HT3 antagonist with dexamethasone, provides superior prevention of PONV. Safety profiles vary among agents; for example, NK1 antagonists have minimal side effects, while dopamine antagonists may cause extrapyramidal symptoms.
Conclusion
Effective management of PONV requires an understanding of the pharmacologic options available. Tailoring antiemetic therapy based on patient risk factors and surgical procedures can significantly improve postoperative comfort and outcomes. Ongoing research continues to optimize antiemetic protocols for better efficacy and safety.